All Things Cardio-Oncology

Dr Vivek Narayan is an Assistant Professor of Medicine at Hospital of the University of Pennsylvania, Philadelphia, US.

View the entire webinar here:
https://www.radcliffecardiology.com/video-index/renal-cell-carcinoma-and-vegf-tki-cardiovascular-toxicity

Richard Cheng MD, MSc. is cardiology faculty at the University of Washington, Seattle, with a focus in cardiomyopathies, cardio-oncology and cardiac imaging. He is Program Director for the HF fellowship and the Director of the Cardio-oncology Program. He has formal training with a Masters-in-Science in clinical trial design and biostatistics. He has extensive editorial experience, including serving on the editorial boards for JACC, JACC: Cardio-oncology, JHLT, and is an associate editor for Heart (BMJ). Additionally, he is topic (section) editor for cardiomyopathies for ACC/HFSA HFSAP and an associate editor for ACC.org for heart failure and cardiomyopathies. His research focus over the last several years has been on risk stratification in heart failure, cardiac amyloidosis, and cardio-oncology cohorts.

Read the full manuscript here:

https://heart.bmj.com/content/early/2024/01/24/heartjnl-2023-323502

Donate to the Rachel Levine Amyloidosis Awareness Fund here:

https://ic-os.info/RachelDaraLavineFund

Dr Saro Armenian is a Pediatric Hematologist-Oncologist at City of Hope's (COH) main campus Duarte, US. He co-leads the COH Cancer Control and Population Sciences Program and directs the Center for Survivorship and Outcomes in the Hematologic Malignancies Research Institute.

Dr Michelle Kittleson is Professor of Medicine at Cedars-Sinai and Director of Education in Heart Failure and Transplantation at the Smidt Heart Institute. She graduated from Harvard College and received her medical degree from Yale University. She completed residency training at Brigham and Women's Hospital and cardiology fellowship at Johns Hopkins, where she also received a PhD in Clinical Investigation.

Watch the complete webinar here: https://www.radcliffecardiology.com/webinars/latest-clinical-trial-updates-attr-cm-and-al-cm

Dr. Paul Cottu, oncologist atInstitut Curie, Paris, FR provides an overview of breast cancer therapies with associated cardiovascular toxicities. The original webinar can be viewed at the link below:

https://www.radcliffecardiology.com/webinars/cardiotoxicity-breast-cancer-challenges-multimodal-therapies

Dr Anne Blaes is a Professor in the Division of Hematology and Oncology at the University of Minnesota. She is the Director of the Screening, Prevention, Etiology, and Cancer Survivorship (SPECS) Program within the Masonic Cancer Center.

View the original webinar here:

https://www.radcliffecardiology.com/webinars/applying-esc-ic-os-guidelines-how-do-we-actually-do-risk-stratification

Ihab Rafic Hamzeh, MD, Associate Professor, Department of Cardiology, The MD Anderson Cancer Center, Houston, TX

This is a highlight from our weekly webinar January 11, 2023. You can view the entire broadcast at the link below.

https://www.radcliffecardiology.com/webinars/cardiovascular-toxicities-novel-cancer-drugs

Dr Kathryn Ruddy is a Professor of Oncology at Mayo Clinic, Rochester, US. She co-leads the Prevention, Survivorship and Care Delivery Programme at Mayo Clinic Comprehensive Cancer Center.

Dr. Ganatra and Dr. Daniel Lenihan discuss an article they both contributed to titled "SGLT2 Inhibitor Use and Risk of Clinical Events in Patients With Cancer Therapy–Related Cardiac Dysfunction"

Article Link

⁠https://www.sciencedirect.com/science/article/abs/pii/S2213177923005966⁠

Dr. Sarju Ganatra is Vice Chair of the Department of Medicine at Lahey Hospital Department of Medicine Research

Follow him on X:

@SarjuGanatraMD

Dan Lenihan and Steve Casselli had a chance to sit down with Dr. Prince Otchere at the San Antonio Breast Cancer Summit 2023 and discuss developments in Ghana, Africa which Prince is helping to pioneer.